Results for
""Norpregnenes""[mesh_terms]

Menopausal symptoms.

Edward Morris, Janice Rymer

Clinical evidence 2005

Menopausal symptoms.

Edward Morris, Janice Rymer

Clinical evidence 2005

Tibolone as Hormonal Therapy and Neuroprotective Agent.

Juan Pablo Del Río, Santiago Molina, Oscar Hidalgo-Lanussa, Luis Miguel Garcia-Segura, George E Barreto

Trends in endocrinology and metabolism: TEM 2021;31(10):742-759

Menopausal symptoms.

Edward Morris, Janice Rymer

Clinical evidence 2006

Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.

George E Christodoulakos, Irene V Lambrinoudaki, Emmanuel V Economou, Constantinos Papadias, Evangelia E Kouskouni, Sofia A Vlachou, George C Creatsas, Constantinos P Panoulis

Journal of cardiovascular pharmacology 2006;47(4):542-8

Effect of tibolone administration on heart rate variability and free fatty acid levels in postmenopausal women.

Daniela Manzella, Felice Fornaro, Marco Carbonella, Ciro Picardi, Giuseppe Paolisso, Nicola Colacurci

Fertility and sterility 2002;78(5):1005-9

Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials.

Małgorzata Bała, Amirhossein Sahebkar, Sorin Ursoniu, Maria-Corina Serban, Anetta Undas, Dimitri P Mikhailidis, Gregory Y H Lip, Jacek Rysz, Maciej Banach

Pharmacological research 2018;124():64-73

Tibolone: new type of hormone replacement.

Harvard women's health watch 2002;9(5):5

Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience.

V Bianco, F Murina, P Roberti, I Valente

Minerva ginecologica 2007;58(4):335-44

Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review.

C Antoine, F Liebens, B Carly, A Pastijn, S Rozenberg

Climacteric : the journal of the International Menopause Society 2007;10(1):23-6

Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.

A M Paoletti, M Orrù, S Floris, M Mannias, A M Vacca, S Ajossa, S Guerriero, G B Melis

Contraception 2000;61(4):259-63

The effect of tibolone treatment on lipid profile in women: A systematic review and dose-response meta-analysis of randomized controlled trials.

Changyu Lv, Wencui Zhang, Xia Tan, Xianping Shang, Mihnea-Alexandru Găman, Hany Salem, Ahmed Abu-Zaid, Xiaohong Wang

Pharmacological research 2022;169():105612

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.

P Angerer, S Störk, W Kothny, P Schmitt, C von Schacky

Arteriosclerosis, thrombosis, and vascular biology 2001;21(2):262-8

Effect of misoprostol on bone mineral density in women with postmenopausal osteoporosis.

Ziya Cebi, Kadir Savan, Necdet Sut, Fehmi Yazicioğlu, Nurhan Utku, Jane Ozcan, Ali Süha Sönmez, Levent Yasar

Prostaglandins & other lipid mediators 2006;79(3-4):199-205

Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications?

I Wiegratz, H Kuhl

Climacteric : the journal of the International Menopause Society 2007;10(4):344-53